Puma Biotech gets EU panel nod for breast cancer drug
(Reuters) - Puma Biotechnology Inc on Friday won a key recommendation from a European Medicines Agency panel on its lead breast cancer drug, five months after the regulator recommended against approving it.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | European Medicines Agency (EMA) | Health